Blaize and Winmate Sign Strategic Partnership Agreement to Bring AI to Rugged Systems for Defense and Critical Infrastructure

A2Z Cust2Mate Solutions to Host First Quarter 2026 Financial Results Conference Call on Friday, May 15, 2026

Helix Energy Solutions Sells Shallow Water Abandonment Business to the Chouest Group

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease

QuantumCore to Present at Canaccord Genuity Virtual Quantum Symposium

NAPCO Security Technologies, Inc. Reports Fiscal 2026 Q3 Results

ICG Silver & Gold Announces Completion of Initial District-Scale Geological Modeling, Increasing Historical Drilling Database to over 40,000 Meters at the Tuscarora District

AIMIA PROVIDES UPDATE ON ITS SHARE BUYBACKS FOR APRIL

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026

BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema

Forgent Power Solutions, Inc. to Report Fiscal Third Quarter 2026 Results

Transaction with Laiva Gold Inc. Receives Conditional CSE Approval

NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI

Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer

Introducing Vylor: Corteva Spinoff to Propel Agriculture Further

Legence Sets First Quarter 2026 Earnings Release Date and Webcast Schedule

Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026

New Data at DDW 2026 Show TissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barrett's Esophagus